Analysis of price variation & formulation aspects of different brands of cefixime marketed in NCR region
Analysis of price variation & formulation aspects of different brands of cefixime marketed in NCR region
Abstract
Abstract
Cefixime tablets are frequently recommended by doctors to cure bacterial infections. Cefixime tablets are commonly prescribed to treat bacterial infections. This antibiotic medication can work either as bacteriostatic or bactericidal. In the NCR region,
Aim & Objective
To identify the Price Variability Among certain brands of Cefixime available NCR region
Methodology
Eight different brands of Cefixime tablets opt for quality control testing. Each brand was subjected to various tests, including evaluation for defects, friability, hardness, disintegration, and dissolution. In total, 10 tablets were tested for each brand to ensure their quality.
Result
Each brand has less than 1% acceptable friability values, except AricefO and Cefilab. Each brand represents hardness values around 8 to 13 N. No defects have been detected in any of the brands. The disintegration and dissolution tests were also tested, performed, and identified.
Discussion
The quality of medicines must be re-evaluated it is run by the regulatory body responsible for ensuring the safety and effectiveness of medicines people use throughout their shelf life.
Keywords: Dissolution, Disintegration, Friability, Hardness & Defects
Downloads
References
Kamimura, T., Kojo, H., Matsumoto, Y., Mine, Y., Goto, S., & Kuwahara, S. (1984). In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic. Antimicrobial agents and chemotherapy, 25(1), 98–104.
Kitamori, N., Iga, K. (1978). Dissolution Profiles of Drugs from Tablets, Journal of Pharmaceutical Sciences, 67(10), , 1436-1439,
Kojo, H., Shigi, Y., & Nishida, M. (1980). A novel method for evaluating the outer membrane permeability to beta-lactamase-stable beta-lactam antibiotics. The Journal of antibiotics, 33(3), 310–316.
Matsumoto, Yoshimi & Kojo, Hitoshi & KAMIMURA, TOSHIAKI & MINE, YASUHIRO & Goto, Satoshi & NISHIDA, MINORU & Kuwahara, Seiji. (1985). The mechanism of action of cefixime, a new oral cephalosporin. CHEMOTHERAPY. 33. 123-133.
Patel, D. & Thiyagu, Rajakannan & Mallayasamy, Surulivelrajan & Patel, Heenaben & Pandey, Sujeet. (2009). Price variability among the oral antibiotics available in a South Indian Tertiary Care Hospital. 3. 1871-1875.
Pathak, P., & Dawane, J. (2016). In vitro Comparison of Generic and Branded Preparations of Amoxicillin with Potassium Clavulanate. Journal of clinical and diagnostic research : JCDR, 10(9), FC07–FC09.
Shah, Z., Dighe, A., Londhe, V. (2015). Pharmacoeconomic study of various brands of antibiotic medications in india. World Journal of Pharmaceutical Research, 4(3), 1600-1606.
Singal, G. L., Nanda, A., & Kotwani, A. (2011). A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India. Indian journal of pharmacology, 43(2), 131–136.
Tsabang, N., Evariste, F., Adamou, B., Bernard, D., Néhémie, D. T., Alembert, T. T., Gabriel, A., Francois, Z., & Benoit, N. T. (2016). Ethnopharmacological studies for sustainable development in Cameroon. Research & Reviews: Journal of Pharmacy and Pharmaceutical Sciences, 5(3), 38-56.
World Health Organization..(2012)– Safety monitoring of medicinal products. Reporting system for the general public.Retrieved from https://www.who.int/publications/i/item/9789241503198
Yang, P., Fujimura, S., Du, Y., Zhang, B., Yang, L., Kawamura, M., Zhang, Z., & Zhai, S. (2021). Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics. Antibiotics (Basel, Switzerland), 10(9), 1096.
Zimmermann, W., & Rosselet, A. (1977). Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics. Antimicrobial agents and chemotherapy, 12(3), 368–372
Copyright (c) 2024 Manvi Aggarwal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.